Progress in Cardiovascular Diseases
IF
6.76
Papers
2370
Papers 2444
1 page of 245 pages (2,444 results)
Newest
#1Massimiliano Ruscica (University of Milan)H-Index: 35
#2Peter E. Penson (LJMU: Liverpool John Moores University)H-Index: 18
Last. Carl J. Lavie (Ochsner Medical Center)H-Index: 121
view all 0 authors...
Inflammation is a marker of arterial disease stemming from cholesterol-dependent to -independent molecular mechanisms. In recent years, the role of inflammation in atherogenesis has been underpinned by pharmacological approaches targeting systemic inflammation that have led to a significant reduction in cardiovascular disease (CVD) risk. Although the use of nutraceuticals to prevent CVD has largely focused on lipid-lowering (e.g, red-yeast rice and omega-3 fatty acids), there is growing interest...
Source
#1Ross Arena (UIC: University of Illinois at Chicago)H-Index: 87
Last. Salvatore Carbone (VCU: Virginia Commonwealth University)H-Index: 26
view all 0 authors...
Coronavirus disease 2019 (COVID-19) continues to have a devastating effect on a global scale. COVID-19 variants continue to arise and counteract vaccination efficacy. As such, preventative health measures, such as social distancing and stay at home mandates, will continue for the foreseeable future. Evidence on those at greatest risk for poor outcomes if infected with COVID-19 has rapidly come to light. It has become clear that those with unhealthy lifestyle characteristics, chronic disease risk...
Source
A naive researcher published a scientific article in a respectable journal. She thought her article was straightforward and defensible. It used only publicly available data, and her findings were consistent with much of the literature on the topic. Her coauthors included two distinguished statisticians. To her surprise her publication was met with unusual attacks from some unexpected sources within the research community. These attacks were by and large not pursued through normal channels of sci...
3 CitationsSource
#1Nishaki Mehta (UVA: University of Virginia)H-Index: 7
#1Nishaki Mehta (Oakland University)
Last. Barry A. Franklin (Oakland University)H-Index: 18
view all 8 authors...
IMPORTANCE It has been suggested that atrial fibrillation (AF) is the new cardiovascular disease epidemic of the 21st century. Clinical cardiology has largely focused on AF treatment and associated stroke prevention rather than preventing AF itself. To reduce the global consequences and associated costs of AF, it is critical to now embrace prevention as a priority. Proactively addressing the risk factors for AF and the underlying unhealthy lifestyle habits that contribute to them, using research...
Source
#1Aashish Gupta (UQ: University of Queensland)H-Index: 2
#2Partha Sardar (UQ: University of Queensland)H-Index: 1
Last. Carl J. Lavie (UQ: University of Queensland)H-Index: 121
view all 5 authors...
1 CitationsSource
#1Virginia L. Mihalick (VCU: Virginia Commonwealth University)H-Index: 2
#2Justin M. Canada (VCU: Virginia Commonwealth University)H-Index: 16
Last. Danielle L. Kirkman (VCU: Virginia Commonwealth University)H-Index: 11
view all 5 authors...
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has presented a global public health emergency. Although predominantly a pandemic of acute respiratory disease, corona virus infectious disease-19 (COVID-19) results in multi-organ damage that impairs cardiopulmonary (CP) function and reduces cardiorespiratory fitness. Superimposed on the CP consequences of COVID-19 is a marked reduction in physical activity that exacerbates CP disease (CPD) risk. CP...
Source
#1Danilo Menichelli (Sapienza University of Rome)H-Index: 11
#2Tommasa Vicario (Sapienza University of Rome)H-Index: 13
Last. Daniele Pastori (Sapienza University of Rome)H-Index: 31
view all 7 authors...
Cancer patients are at an increased risk of developing atrial fibrillation (AF) and thrombosis. However, the management of anticoagulation in patients with both diseases may be challenging, and data on these patients are lacking. We summarize the current evidence on the incidence and prevalence of cancer in AF and vice versa and provide some practical considerations on the management of oral anticoagulation in specific clinical situations. Low-molecular weight heparins are not approved for throm...
1 CitationsSource
#1Fatima Ali-Ahmed (Mayo Clinic)
#2Frederik Dalgaard (Gentofte Hospital)H-Index: 8
Last. Sana M. Al-Khatib (Duke University)H-Index: 76
view all 8 authors...
Abstract Background: Cardiac resynchronization therapy (CRT) has been demonstrated to improve heart failure (HF) symptoms, reverse LV remodeling, and reduce mortality and HF hospitalization (HFH) in patients with a reduced left ventricular (LV) ejection fraction (LVEF). Prior studies examining outcomes based on right ventricular (RV) lead position among CRT patients have provided mixed results. We performed a systematic review and meta-analysis of randomized controlled trials and prospective obs...
Source
#1Jose F. Huizar (VCU: Virginia Commonwealth University)H-Index: 14
#2Alex Y. Tan (VCU: Virginia Commonwealth University)H-Index: 25
Last. Kenneth A. Ellenbogen (VCU: Virginia Commonwealth University)H-Index: 77
view all 5 authors...
The medical community's understanding of the consequences of premature ventricular contractions (PVCs) and PVC-induced cardiomyopathy has been derived mostly from observational and large population-based studies. Due to the difficulty of predicting the development of PVC-cardiomyopathy, the acute and chronic cardiac effects of PVCs and the mechanism of PVC-cardiomyopathy have been derived from pre-clinical studies with large animal models. Recently, these studies have described myocardial substr...
Source
#1Ann Canterbury (University of Pittsburgh)H-Index: 2
#2Samir Saba (University of Pittsburgh)H-Index: 40
Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure (HF), myocardial dysfunction and prolonged ventricular depolarization on surface electrocardiogram. CRT can be delivered by a pacemaker (CRTP) or a combined pacemaker-defibrillator (CRTD). Although these two types of devices are very different in size, function, and cost, current published guidelines do not distinguish between them, leaving the choice of which device to implant to the treating phy...
Source
12345678910
Top fields of study
Cardiology
Intensive care medicine
Heart failure
Disease
Heart disease
Myocardial infarction
Diabetes mellitus
Medicine